Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Infectious Disease

Vaccine/Immunotherapy

COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): A multicenter, prospective, case-control study

The Lancet: Gastroenterology & Hepatology | Feb 08, 2022 Vaccine/Immunotherapy

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomized, placebo-controlled, multicenter phase 2 clinical trial

PLoS Medicine | Feb 04, 2022 Vaccine/Immunotherapy

Vaccinating veterans for COVID-19 at the US Department of Veterans Affairs

American Journal of Preventive Medicine | Feb 03, 2022 Vaccine/Immunotherapy

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: A phase 2 and 3 multicenter, double-blind, randomized, placebo-controlled trial

The Lancet | Feb 01, 2022 Vaccine/Immunotherapy

Association of a third dose of BNT162b2 vaccine with incidence of SARS-CoV-2 infection among healthcare workers in Israel

JAMA | Jan 28, 2022 Vaccine/Immunotherapy

Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021

JAMA | Jan 28, 2022 Vaccine/Immunotherapy

Durability of antibody levels after vaccination with mRNA SARS-CoV-2 vaccine in individuals with or without prior infection

JAMA | Jan 06, 2022 Vaccine/Immunotherapy

Maternal and neonatal SARS-CoV-2 immunoglobulin G antibody levels at delivery after receipt of the BNT162b2 messenger RNA COVID-19 vaccine during the second trimester of pregnancy

JAMA | Dec 25, 2021 Vaccine/Immunotherapy

Multisystem inflammatory syndrome in children by COVID-19 vaccination status of adolescents in France

JAMA | Dec 24, 2021 Vaccine/Immunotherapy

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): A blinded, multicentre, randomised, controlled, phase 2 trial

The Lancet | Dec 23, 2021 Vaccine/Immunotherapy

« Prev 1 2 3 4 5 … 52 Next »

COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): A multicenter, prospective, case-control study

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomized, placebo-controlled, multicenter phase 2 clinical trial

Vaccinating veterans for COVID-19 at the US Department of Veterans Affairs

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: A phase 2 and 3 multicenter, double-blind, randomized, placebo-controlled trial

Association of a third dose of BNT162b2 vaccine with incidence of SARS-CoV-2 infection among healthcare workers in Israel

Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021

Durability of antibody levels after vaccination with mRNA SARS-CoV-2 vaccine in individuals with or without prior infection

Maternal and neonatal SARS-CoV-2 immunoglobulin G antibody levels at delivery after receipt of the BNT162b2 messenger RNA COVID-19 vaccine during the second trimester of pregnancy

Multisystem inflammatory syndrome in children by COVID-19 vaccination status of adolescents in France

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): A blinded, multicentre, randomised, controlled, phase 2 trial

The Role of Nutrition in Enhancing Fertility for Men and Women

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Effect of Collagen Vascular Diseases on Eyes: MCQ Challenge

The Role of Omega-3 Fatty Acids in Inflammation and Cardiovascular Health

Leptin Hormone: Its Role in Food Intake & Energy Expenditure

COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): A multicenter, prospective, case-control study

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomized, placebo-controlled, multicenter phase 2 clinical trial

Vaccinating veterans for COVID-19 at the US Department of Veterans Affairs

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: A phase 2 and 3 multicenter, double-blind, randomized, placebo-controlled trial

Association of a third dose of BNT162b2 vaccine with incidence of SARS-CoV-2 infection among healthcare workers in Israel

Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021

Durability of antibody levels after vaccination with mRNA SARS-CoV-2 vaccine in individuals with or without prior infection

Maternal and neonatal SARS-CoV-2 immunoglobulin G antibody levels at delivery after receipt of the BNT162b2 messenger RNA COVID-19 vaccine during the second trimester of pregnancy

Multisystem inflammatory syndrome in children by COVID-19 vaccination status of adolescents in France

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): A blinded, multicentre, randomised, controlled, phase 2 trial

The Role of Nutrition in Enhancing Fertility for Men and Women

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Effect of Collagen Vascular Diseases on Eyes: MCQ Challenge

The Role of Omega-3 Fatty Acids in Inflammation and Cardiovascular Health

Leptin Hormone: Its Role in Food Intake & Energy Expenditure

Select Specialty

Select Topic